Skip to main content
Larissa Pharma

Cetirizine diHCl

Cetirizine diHCl — second-generation h1 antihistamine. CAS 83881-52-1. Supplied with CoA, MSDS and batch traceability records.

About this ingredient

Cetirizine dihydrochloride is the active metabolite of hydroxyzine and antagonises peripheral H1 receptors selectively. It crosses the blood-brain barrier only slightly, causing markedly less sedation than first-generation antihistamines.

Formulation note

Distinctly bitter — chewable and liquid presentations need a taste-masking system or coating.

CAS number
83881-52-1
Therapeutic class
Second-generation H1 antihistamine
Typical dosage forms
Film-coated tablets · Syrup · Oral drops
Pharmacopoeia grade
Confirmed at quotation
Manufacturer
Audited GMP facility
USPBPEPJPIP
Documentation

Supplied with every batch

The documents below ship with the material, ready for regulatory dossiers and GMP inspection.

  • 01

    CoA

    Certificate of Analysis

  • 02

    MSDS

    Material Safety Data Sheet

  • 03

    CO

    Certificate of Origin

  • 04

    CQ

    Certificate of Quality

  • 05

    GMP

    Manufacturer GMP certificate

  • 06

    DMF

    Drug Master File, where available

Need a quotation or a sample?

Send the ingredient name, grade and expected quantity. Our commercial team responds within one business day.